A severe (type II) hepatopulmonary syndrome in a patient with idiopathic portal hypertension and treatment with paroxetine

Netherlands Journal of Medicine

Volumn 63, Issue 11, 2005, Pages 448-452

  Yilmaz, Şerif ^a   Dursum, M ^a   Canoruc F ^a   Bayan, K ^a   Karabulut, A ^a   Akay, H ^a  

^a DICLE UNIVERSITY   (Turkey)

Author keywords

Hepatopulmonary syndrome; Paroxetine

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; LACTATE DEHYDROGENASE; MACROSALB TC 99M; NITRIC OXIDE SYNTHASE; PAROXETINE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTERIAL CARBON DIOXIDE TENSION; ARTERIAL OXYGEN TENSION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLOOD PRESSURE MEASUREMENT; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; DRUG ACTIVITY; ENZYME INHIBITION; HEART CATHETERIZATION; HEART OUTPUT; HEPATOPULMONARY SYNDROME; HISTOPATHOLOGY; HUMAN; IDIOPATHIC DISEASE; LABORATORY TEST; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER BIOPSY; LUNG FUNCTION TEST; LUNG SCINTISCANNING; MAJOR DEPRESSION; MALE; PHYSICAL EXAMINATION; PORTAL HYPERTENSION; THORAX RADIOGRAPHY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

ADOLESCENT; HEPATOPULMONARY SYNDROME; HUMANS; HYPERTENSION, PORTAL; MALE; PAROXETINE; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 29644435761     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Krowka MJ. Hepatopulmonary syndrome: recent literature (1997 to 1999) and implications for liver transplantation. Liver Transpl 2000;6(4 Suppl 1):S31-5.
2. Naeije R, Melot C, Hallemans R, et al. Pulmonary hemodynamics in liver cirrhosis. Semin Respir Med 1985;7:164-71.
3. Martinez GP, Barbera JA, Visa J, et al. Hepatopulmonary syndrome in candidates for liver transplantation. J Hepatol 2001;34:651-7.
4. Lima BL, Franca AV, Pazin-Filho A, et al. Frequency, clinical characteristics, and respiratory parameters of hepatopulmonary syndrome. Mayo Clin Proc 2004;79(1):42-8.
5. Babbs C, Warnes TW, Haboubi NY. Non-cirrhotic portal hypertension with hypoxaemia. Gut 1988;29(1):129-31.
6. Kaymakoglu S, Kahraman T, Kudat H, et al. Hepatopulmonary syndrome in noncirrhotic portal hypertensive patients. Dig Dis SCi 2003;48(3):556-60.
7. Gaines DI, Fallon MB. Hepatopulmonary syndrome. Liver Int 2004;24(5):397-401.
8. Pomier-Layrargues G. TIPS and hepatic encephalopathy. Semin Liver Dis 1996;16:315-20.
9. Meyer CA, White CS, Sherman KE. Diseases of the hepatopulmonary axis. Radiographics 2000;20(3):687-98.
10. De BK, Sen S, Biswas PK, et al. Hepatopulmonary syndrome in inferior vena cava obstruction responding to cavoplasty. Gastroenterology 2000;118(1):192-6.
11. Asbert M, Gines A, Gines P. Circulating levels of endothelin in liver cirrhosis. Gastroenterology 1993;104:1485-91.
12. Castro M, Krowka MJ. Hepatopulmonary syndrome. A pulmonary vascular complication of liver disease. Clin Chest Med 1996;17(1):35-48.
13. Bernard PH, Le Bail B, Cransac M, et al. Progression from idiopathic portal hypertension to incomplete septal cirrhosis with liver failure requiring liver transplantation. J Hepatol 1995;22:495-9.
14. Wanless IE. Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules. Hepatology 1990;11:787-97.
15. Hillaire S, Bonte E, Denninger MH, et al. Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: a re-evaluation in 28 patients. Gut 2002;51(2):275-80.
16. Poterucha JJ, Krowka MJ, Dickson ER. Failure of hepatopulmonary syndrome to resolve after liver transplantation and successful treatment with embolotherapy. Hepatology 1995;21:96-100.
17. Lange PA, Stoller JK. The hepatopulmonary syndrome. Effects of liver transplantation. Clin Chest Med 1996;17:115-23.
18. Altschuler EL, Kast RE. Paroxetine for hepatopulmonary syndrome? Med Hypotheses 2004;62(3):446-7.